Placebo (Part 2 - MAD)

DRUG3 trials

Sponsors

Chiesi Farmaceutici S.p.A.

Conditions

Chronic Obstructive Pulmonary DiseaseCystic FibrosisNon-Cystic Fibrosis BronchiectasisPulmonary Fibrosis

Phase 1

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD

TerminatedNCT02815488

Chiesi Farmaceutici S.p.A.Chronic Obstructive Pulmonary Disease

Start: 2016-01-22End: 2019-03-31Updated: 2020-04-17

A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects

CompletedNCT03056326

Chiesi Farmaceutici S.p.A.Cystic Fibrosis, Non-Cystic Fibrosis Bronchiectasis

Start: 2016-11-30End: 2017-07-31Updated: 2017-11-07

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure

CompletedNCT06746064

Chiesi Farmaceutici S.p.A.Pulmonary Fibrosis

Start: 2025-01-13End: 2026-02-04Updated: 2026-02-12